𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients

✍ Scribed by Eugenio Ramirez; Luis Cartier; Mauricio Torres; Marcelo Barria


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
229 KB
Volume
79
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Human T‐cell lymphotropic virus type I (HTLV‐I) is the etiologic agent of HTLV‐I‐associated myelopathy/tropical spastic paraparesis (HAM/TSP). High HTLV‐I provirus load and tax mRNA level have been suggested as predictors of disease progression in patients with HAM/TSP, but little is known about the temporal variation in patients. To clarify the role of high proviral and tax mRNA loads and their fluctuations in the pathogenesis of HAM/TSP, we measured proviral load and tax mRNA in serially collected peripheral blood mononuclear cells (PBMCs) from nine patients with HAM/TSP during a long‐term follow‐up, by use of real‐time polymerase chain reaction using tax primers. The real‐time PCR quantitation revealed a wide range of variation of proviral loads (7.82–97.13 copies per 100 PBMCs) and tax mRNA (0.20–245.30 copies) among HAM/TSP patients. Patients showed three different patterns of HTLV‐I tax mRNA loads during the course of the disease. Tax mRNA load showed a separate evolution with respect to the disease. The dynamic patterns of proviral load and mRNA Tax expression suggest that only the permanent presence of a basal level of tax mRNA, rather than the tax mRNA load, is related to the development of HAM/TSP. To our knowledge, this is the first longitudinal study to determine tax mRNA expression at different clinical stages. J. Med. Virol. 79: 782–790, 2007. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Molecular and clinical effects of betame
✍ Carolina Alberti; Luis Cartier; María A. Valenzuela; Javier Puente; Yuetsu Tanak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB

## Abstract There is no effective therapy for human T‐cell lymphotropic virus type I (HTLV‐I)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP). Glucocorticoids are effective to reduce the motor disability in these patients, but its role as anti‐spastic drugs is unknown. Here it is repor

Increases levels of circulating intercel
✍ Dr.; MD; PhD N. Tsukada; MD; PhD K. Miyagi; MD; PhD M. Matsuda; MD; PhD N. Yanag 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 3 views

We evaluated the presence of soluble intercellular adhesion molecule-1 (SICAM-I) antigen in the sera of patients with multiple sclerosis and human T-lymphotropic virus type I (HTLV-I)-associated myelopathy (HAM) using an enzyme-linked immunosorbent assay. Patients with multiple sclerosis in the acti

Human T cell lymphotropic virus type 1 (
✍ Maria Fernanda Rios Grassi; Viviana Nilla Olavarria; Ramon de Almeida Kruschewsk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract A high human T‐cell lymphotropic virus type 1 (HTLV‐1) proviral load is described in HTLV‐1‐associated diseases, especially HAM/TSP. However, the cut‐off value to define high levels of HTLV‐1 proviral load is not well established. 281 HTLV‐1‐infected patients from the HTLV reference cen